275 related articles for article (PubMed ID: 10809788)
21. YC-1-inhibited proliferation of rat mesangial cells through suppression of cyclin D1-independent of cGMP pathway and partially reversed by p38 MAPK inhibitor.
Chiang WC; Teng CM; Lin SL; Chen YM; Tsai TJ; Hsieh BS
Eur J Pharmacol; 2005 Jul; 517(1-2):1-10. PubMed ID: 15950964
[TBL] [Abstract][Full Text] [Related]
22. Adenovirus-mediated gene transfer of MMAC1/PTEN to glioblastoma cells inhibits S phase entry by the recruitment of p27Kip1 into cyclin E/CDK2 complexes.
Cheney IW; Neuteboom ST; Vaillancourt MT; Ramachandra M; Bookstein R
Cancer Res; 1999 May; 59(10):2318-23. PubMed ID: 10344736
[TBL] [Abstract][Full Text] [Related]
23. TGF-beta1-induced cell cycle arrest in renal mesangial cells involves inhibition of cyclin E-cdk 2 activation and retinoblastoma protein phosphorylation.
Schoecklmann HO; Rupprecht HD; Zauner I; Sterzel RB
Kidney Int; 1997 Apr; 51(4):1228-36. PubMed ID: 9083291
[TBL] [Abstract][Full Text] [Related]
24. Thyrotropin-induced mitogenesis is Ras dependent but appears to bypass the Raf-dependent cytoplasmic kinase cascade.
al-Alawi N; Rose DW; Buckmaster C; Ahn N; Rapp U; Meinkoth J; Feramisco JR
Mol Cell Biol; 1995 Mar; 15(3):1162-8. PubMed ID: 7862110
[TBL] [Abstract][Full Text] [Related]
25. Insulin-like growth factor-I extends in vitro replicative life span of skeletal muscle satellite cells by enhancing G1/S cell cycle progression via the activation of phosphatidylinositol 3'-kinase/Akt signaling pathway.
Chakravarthy MV; Abraha TW; Schwartz RJ; Fiorotto ML; Booth FW
J Biol Chem; 2000 Nov; 275(46):35942-52. PubMed ID: 10962000
[TBL] [Abstract][Full Text] [Related]
26. Somatostatin is expressed in FRTL-5 thyroid cells and prevents thyrotropin-mediated down-regulation of the cyclin-dependent kinase inhibitor p27kip1.
Medina DL; Velasco JA; Santisteban P
Endocrinology; 1999 Jan; 140(1):87-95. PubMed ID: 9886811
[TBL] [Abstract][Full Text] [Related]
27. Estrogen-induced activation of Cdk4 and Cdk2 during G1-S phase progression is accompanied by increased cyclin D1 expression and decreased cyclin-dependent kinase inhibitor association with cyclin E-Cdk2.
Prall OW; Sarcevic B; Musgrove EA; Watts CK; Sutherland RL
J Biol Chem; 1997 Apr; 272(16):10882-94. PubMed ID: 9099745
[TBL] [Abstract][Full Text] [Related]
28. Regulation of the phosphatidylinositol 3-kinase, Akt/protein kinase B, FRAP/mammalian target of rapamycin, and ribosomal S6 kinase 1 signaling pathways by thyroid-stimulating hormone (TSH) and stimulating type TSH receptor antibodies in the thyroid gland.
Suh JM; Song JH; Kim DW; Kim H; Chung HK; Hwang JH; Kim JM; Hwang ES; Chung J; Han JH; Cho BY; Ro HK; Shong M
J Biol Chem; 2003 Jun; 278(24):21960-71. PubMed ID: 12668683
[TBL] [Abstract][Full Text] [Related]
29. Retinoic acid-mediated G1 arrest is associated with induction of p27(Kip1) and inhibition of cyclin-dependent kinase 3 in human lung squamous carcinoma CH27 cells.
Hsu SL; Hsu JW; Liu MC; Chen LY; Chang CD
Exp Cell Res; 2000 Aug; 258(2):322-31. PubMed ID: 10896783
[TBL] [Abstract][Full Text] [Related]
30. The cyclin D3-CDK4-p27kip1 holoenzyme in thyroid epithelial cells: activation by TSH, inhibition by TGFbeta, and phosphorylations of its subunits demonstrated by two-dimensional gel electrophoresis.
Coulonval K; Bockstaele L; Paternot S; Dumont JE; Roger PP
Exp Cell Res; 2003 Nov; 291(1):135-49. PubMed ID: 14597415
[TBL] [Abstract][Full Text] [Related]
31. cAMP signaling selectively influences Ras effectors pathways.
Ciullo I; Diez-Roux G; Di Domenico M; Migliaccio A; Avvedimento EV
Oncogene; 2001 Mar; 20(10):1186-92. PubMed ID: 11313862
[TBL] [Abstract][Full Text] [Related]
32. Cyclic AMP-dependent phosphorylation of cyclin D3-bound CDK4 determines the passage through the cell cycle restriction point in thyroid epithelial cells.
Paternot S; Coulonval K; Dumont JE; Roger PP
J Biol Chem; 2003 Jul; 278(29):26533-40. PubMed ID: 12730225
[TBL] [Abstract][Full Text] [Related]
33. The p85 regulatory subunit of PI3K mediates TSH-cAMP-PKA growth and survival signals.
De Gregorio G; Coppa A; Cosentino C; Ucci S; Messina S; Nicolussi A; D'Inzeo S; Di Pardo A; Avvedimento EV; Porcellini A
Oncogene; 2007 Mar; 26(14):2039-47. PubMed ID: 17043656
[TBL] [Abstract][Full Text] [Related]
34. Fibroblast growth factor inhibits chondrocytic growth through induction of p21 and subsequent inactivation of cyclin E-Cdk2.
Aikawa T; Segre GV; Lee K
J Biol Chem; 2001 Aug; 276(31):29347-52. PubMed ID: 11384971
[TBL] [Abstract][Full Text] [Related]
35. Stimulation of pancreatic beta-cell replication by incretins involves transcriptional induction of cyclin D1 via multiple signalling pathways.
Friedrichsen BN; Neubauer N; Lee YC; Gram VK; Blume N; Petersen JS; Nielsen JH; Møldrup A
J Endocrinol; 2006 Mar; 188(3):481-92. PubMed ID: 16522728
[TBL] [Abstract][Full Text] [Related]
36. Thyrotropin activates mitogen-activated protein kinase pathway in FRTL-5 by a cAMP-dependent protein kinase A-independent mechanism.
Iacovelli L; Capobianco L; Salvatore L; Sallese M; D'Ancona GM; De Blasi A
Mol Pharmacol; 2001 Nov; 60(5):924-33. PubMed ID: 11641420
[TBL] [Abstract][Full Text] [Related]
37. Cyclin E-cdk2 activation is associated with cell cycle arrest and inhibition of DNA replication induced by the thymidylate synthase inhibitor Tomudex.
Yin MB; Guo B; Panadero A; Frank C; Wrzosek C; Slocum HK; Rustum YM
Exp Cell Res; 1999 Feb; 247(1):189-99. PubMed ID: 10047461
[TBL] [Abstract][Full Text] [Related]
38. Protein kinase A-dependent and -independent signaling pathways contribute to cyclic AMP-stimulated proliferation.
Cass LA; Summers SA; Prendergast GV; Backer JM; Birnbaum MJ; Meinkoth JL
Mol Cell Biol; 1999 Sep; 19(9):5882-91. PubMed ID: 10454535
[TBL] [Abstract][Full Text] [Related]
39. Limiting amounts of p27Kip1 correlates with constitutive activation of cyclin E-CDK2 complex in HTLV-I-transformed T-cells.
Cereseto A; Washington Parks R; Rivadeneira E; Franchini G
Oncogene; 1999 Apr; 18(15):2441-50. PubMed ID: 10229195
[TBL] [Abstract][Full Text] [Related]
40. Molecular mechanisms underlying interferon-alpha-induced G0/G1 arrest: CKI-mediated regulation of G1 Cdk-complexes and activation of pocket proteins.
Sangfelt O; Erickson S; Castro J; Heiden T; Gustafsson A; Einhorn S; Grandér D
Oncogene; 1999 May; 18(18):2798-810. PubMed ID: 10362250
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
